spb/firc0001_uqo

1\begin{tabular}{lrrrrrrr}2\toprule3form\_type & item & project\_type & mentions & matched & pct & matched\_amount\_gusd & total\_amount\_gusd \\4\midrule58-K & full\_body & ma\_integration & 41{,}635 & 6{,}055 & 14.54 & 4{,}431.64 & 21{,}674.49 \\610-Q & md\_and\_a & ma\_integration & 32{,}011 & 319 & 1.0 & 297.7 & 15{,}025.4 \\710-Q & financial\_statements & ma\_integration & 19{,}165 & 260 & 1.36 & 158.12 & 7{,}994.15 \\810-K & md\_and\_a & ma\_integration & 14{,}027 & 60 & 0.43 & 159.74 & 6{,}818.94 \\910-Q & md\_and\_a & drug\_pipeline & 12{,}341 & 1 & 0.01 &  & 161.52 \\1010-K & business & ma\_integration & 10{,}554 & 21 & 0.2 & 3.23 & 7{,}258.55 \\118-K & full\_body & capex\_program & 10{,}415 & 7{,}135 & 68.51 & 5{,}436.73 & 7{,}873.23 \\1210-Q & md\_and\_a & geographic\_expansion & 7{,}602 & 2 & 0.03 &  & 461.42 \\1310-Q & md\_and\_a & plant\_construction & 6{,}624 & 1 & 0.02 & 3.0 & 882.35 \\1410-Q & md\_and\_a & product\_launch & 5{,}935 & 1 & 0.02 &  & 119.1 \\1510-Q & md\_and\_a & partnership & 5{,}563 & 38 & 0.68 & 16.44 & 2{,}199.1 \\1610-Q & md\_and\_a & rd\_program & 5{,}221 & 0 & 0.0 &  & 169.15 \\178-K & full\_body & partnership & 4{,}919 & 170 & 3.46 & 127.29 & 1{,}238.44 \\1810-Q & unregistered\_sales & ma\_integration & 4{,}565 & 2{,}334 & 51.13 & 1{,}995.02 & 2{,}281.79 \\1910-Q & md\_and\_a & cost\_reduction & 4{,}437 & 111 & 2.5 & 79.52 & 571.57 \\208-K & full\_body & drug\_pipeline & 4{,}308 & 4 & 0.09 & 0.25 & 118.97 \\2110-Q & md\_and\_a & capex\_program & 4{,}088 & 856 & 20.94 & 796.27 & 2{,}998.47 \\2210-K & md\_and\_a & drug\_pipeline & 3{,}992 & 0 & 0.0 &  & 28.52 \\2310-Q & md\_and\_a & manufacturing\_expansion & 3{,}870 & 3 & 0.08 &  & 182.76 \\2410-Q & controls\_and\_procedures & ma\_integration & 3{,}536 & 5 & 0.14 & 0.43 & 248.21 \\258-K & full\_body & cost\_reduction & 3{,}361 & 643 & 19.13 & 266.15 & 807.44 \\2610-K & properties & plant\_construction & 3{,}266 & 0 & 0.0 &  & 132.04 \\2710-K & md\_and\_a & geographic\_expansion & 3{,}156 & 2 & 0.06 &  & 363.7 \\2810-K & business & drug\_pipeline & 3{,}141 & 0 & 0.0 &  & 25.43 \\2910-Q & md\_and\_a & infrastructure & 3{,}047 & 4 & 0.13 & 1.85 & 3{,}464.59 \\3010-K & business & geographic\_expansion & 2{,}833 & 0 & 0.0 &  & 658.32 \\3110-Q & controls\_and\_procedures & erp\_implementation & 2{,}703 & 0 & 0.0 &  & 61.61 \\3210-Q & md\_and\_a & digital\_transformation & 2{,}484 & 0 & 0.0 &  & 67.68 \\3310-K & business & product\_launch & 2{,}462 & 0 & 0.0 &  & 51.71 \\3410-Q & md\_and\_a & technology\_deployment & 2{,}410 & 35 & 1.45 & 16.79 & 179.42 \\3510-K & md\_and\_a & plant\_construction & 2{,}310 & 3 & 0.13 & 0.34 & 286.23 \\3610-K & md\_and\_a & product\_launch & 2{,}285 & 0 & 0.0 &  & 80.96 \\3710-K & md\_and\_a & partnership & 2{,}246 & 16 & 0.71 & 7.36 & 223.79 \\3810-Q & risk\_factors & ma\_integration & 2{,}133 & 20 & 0.94 & 10.78 & 962.24 \\3910-K & md\_and\_a & rd\_program & 2{,}001 & 0 & 0.0 &  & 125.19 \\408-K & full\_body & plant\_construction & 1{,}983 & 23 & 1.16 & 4.29 & 685.84 \\4110-K & business & rd\_program & 1{,}898 & 0 & 0.0 &  & 186.29 \\4210-K & business & partnership & 1{,}880 & 1 & 0.05 & 0.3 & 132.91 \\4310-Q & unregistered\_sales & capex\_program & 1{,}740 & 1{,}419 & 81.55 & 1{,}841.69 & 1{,}972.31 \\4410-Q & financial\_statements & drug\_pipeline & 1{,}735 & 0 & 0.0 &  & 9.85 \\4510-K & business & plant\_construction & 1{,}671 & 1 & 0.06 & 0.51 & 104.63 \\4610-Q & financial\_statements & partnership & 1{,}664 & 56 & 3.37 & 35.31 & 185.07 \\478-K & full\_body & infrastructure & 1{,}651 & 24 & 1.45 & 15.03 & 540.82 \\4810-K & md\_and\_a & cost\_reduction & 1{,}564 & 23 & 1.47 & 15.4 & 216.18 \\4910-K & md\_and\_a & capex\_program & 1{,}507 & 372 & 24.68 & 392.53 & 1{,}848.99 \\5010-Q & financial\_statements & cost\_reduction & 1{,}448 & 159 & 10.98 & 112.79 & 201.78 \\5110-K & md\_and\_a & manufacturing\_expansion & 1{,}392 & 3 & 0.22 & 0.02 & 107.1 \\5210-Q & financial\_statements & plant\_construction & 1{,}385 & 6 & 0.43 & 2.18 & 168.42 \\5310-Q & unregistered\_sales & cost\_reduction & 1{,}381 & 1{,}212 & 87.76 & 1{,}020.25 & 1{,}033.64 \\548-K & full\_body & geographic\_expansion & 1{,}286 & 12 & 0.93 & 1.71 & 122.93 \\5510-K & business & technology\_deployment & 1{,}265 & 8 & 0.63 & 10.52 & 86.41 \\5610-K & properties & geographic\_expansion & 1{,}219 & 2 & 0.16 & 0.49 & 59.64 \\578-K & full\_body & technology\_deployment & 1{,}177 & 202 & 17.16 & 126.57 & 317.1 \\5810-K & md\_and\_a & digital\_transformation & 1{,}090 & 0 & 0.0 &  & 12.71 \\5910-K & md\_and\_a & infrastructure & 1{,}067 & 3 & 0.28 & 2.16 & 1{,}525.2 \\6010-K & business & digital\_transformation & 1{,}050 & 0 & 0.0 &  & 84.4 \\6110-K & business & manufacturing\_expansion & 1{,}025 & 0 & 0.0 &  & 62.95 \\6210-K & md\_and\_a & technology\_deployment & 978 & 27 & 2.76 & 13.61 & 52.45 \\638-K & full\_body & rd\_program & 968 & 4 & 0.41 & 0.75 & 217.38 \\6410-K & properties & manufacturing\_expansion & 913 & 0 & 0.0 &  & 11.22 \\65\multicolumn{8}{l}{\ldots 232 more rows in \texttt{results/fp\_classes/financing\_regex\_by\_item\_type.csv}} \\66\bottomrule67\end{tabular}68